HopeStage
Back to all studies
RecruitingNCT06767566

Ketamine levels after cesarean birth in people with postpartum depression or pain

About this titleRead the official source — NCT06767566
Medication studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

After cesarean delivery, participants in the postpartum group receive a 12-hour ketamine infusion: a one-hour loading infusion followed by an 11-hour maintenance infusion. Healthy control participants receive the same infusion protocol for comparison. The study measures how ketamine is processed in the body.

Listed locations
Pittsburgh and 1 more locationSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 28, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
50
Sponsor
University of Utah
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06767566
Official title
Show the full official title

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

Recruitment & locations

Currently recruiting

Pittsburgh · Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Utah, a university.

Does this study involve medication?

Yes. The study involves medication, including Ketamine (Ketalar).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies